Lyell Immunopharma (LYEL) Return on Capital Employed Growth (3y) (2024 - 2026)
Lyell Immunopharma (LYEL) Return on Capital Employed Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,440.76 Bn | 66,440.47 Bn | - | - |
| 2 | Nanobiotix | 1,880.51 Bn | 1,880.45 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 467.94 Bn | 463.15 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 122.63 Bn | 115.38 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 70.30 Bn | 61.54 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 62.81 Bn | 62.81 Bn | - | - |
| 8 | Argenx Se | 55.78 Bn | 50.59 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.33 Bn | 34.32 Bn | 959.66 Mn | 4,853.00 |
| 10 | Lyell Immunopharma | 278.70 Mn | 278.70 Mn | - | -6,249.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6,249.00 |
| Dec 31, 2025 | -6,267.00 |
| Sep 30, 2025 | -7,081.00 |
| Jun 30, 2025 | -7,575.00 |
| Mar 31, 2025 | -6,451.00 |
| Dec 31, 2024 | -5,233.00 |
| Sep 30, 2024 | -1,809.00 |